More
    Guided Solutions - Connecting Talent With Innovation/div>

    Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

    Elekta Harmony linear accelerator cleared by U.S. Food and Drug Administration Elekta (EKTA-B.ST) announced todaythat its Elekta Harmony* radiation therapy system recently received U.S....

    Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

    Elekta Harmony linear accelerator cleared by U.S. Food and Drug Administration Elekta (EKTA-B.ST) announced...

    Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure

    Study Results Validate Superiority of Basivertebral Nerve Ablation Compared to Standard Care, With Similar Improvements Demonstrated in Crossover Population

    ONWARD Receives FDA Breakthrough Device Designation for ARC-IM for Blood Pressure and Trunk Control in Spinal Cord Injury

    ONWARD announced the Company has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for their ARC-IM platform...

    Amalgam Rx™ and Novo Nordisk® Plan Global Expansion

    Insulin Titration App, Dose Check®, to Reach Patients Worldwide Amalgam Rx, Inc., the leader in connecting healthcare providers and...

    Get Weekly Newsletter

    Finance

    Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

    Elekta Harmony linear accelerator cleared by U.S. Food and Drug Administration Elekta (EKTA-B.ST) announced...

    Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure

    Study Results Validate Superiority of Basivertebral Nerve Ablation Compared to Standard Care, With Similar Improvements Demonstrated in Crossover Population

    ONWARD Receives FDA Breakthrough Device Designation for ARC-IM for Blood Pressure and Trunk Control in Spinal Cord Injury

    ONWARD announced the Company has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for their ARC-IM platform...

    Amalgam Rx™ and Novo Nordisk® Plan Global Expansion

    Insulin Titration App, Dose Check®, to Reach Patients Worldwide Amalgam Rx, Inc., the leader in connecting healthcare providers and...

    Funding

    GV leads $72M investment in startup offering virtual behavioral healthcare for kids

    Brightline focuses on providing virtual behavioral health solutions for kids. The startup plans to put the new funds to use by launching...

    Health startup lands £4.2m seed funding to “revolutionise” reproductive healthcare

    A health startup aiming to ‘revolutionise’ hormonal and reproductive health has secured multi-million pound investment.

    Lyra Health Completes $200M Funding Round to Transform Mental Health Care Globally

     Lyra Health, the leading provider of comprehensive mental health care benefits for employers, announced it has completed a $200M financing. Coatue led...

    Clinical Trials

    Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure

    Study Results Validate Superiority of Basivertebral Nerve Ablation Compared to Standard Care, With Similar Improvements Demonstrated in Crossover Population

    LivaNova Brings the Conversation Back to Neuromodulation with New IDE

    LivaNova is developing the aura6000 System to treat obstructive sleep apnea. The device will be evaluated in the OSPREY RCT Trial. The...

    CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting

    CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day...

    Navigation Sciences™ Begins First-in-Human Clinical Feasibility Trial of its Pioneering, NaviSci™ System

    Navigation Sciences today announced that the initial patient has participated in the first-in-human clinical feasibility trial of its NaviSci™ System for use...
    1,663FollowersFollow

    Innovation

    Acquisition of freehold site for £4.25m

    Expansion of Chepstow footprint to support commercial roll-out Creo Medical Group plc (AIM: CREO), the medical device company focused...

    Vietnamese health tech firm develops AI model for TB diagnosis, screening

    VinBrain, an AI healthcare software developer in Vietnam, recently came up with an AI model for the diagnosis and screening of tuberculosis.

    Cromwell Hospital Introduces Revolutionary ViewRay MRIdian MR Linac

    GenesisCare’s Centre for Radiotherapy at Cromwell Hospital in London. Patients from across the UK...

    Regulatory Approvals

    Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

    Elekta Harmony linear accelerator cleared by U.S. Food and Drug Administration Elekta (EKTA-B.ST) announced...

    Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure

    Study Results Validate Superiority of Basivertebral Nerve Ablation Compared to Standard Care, With Similar Improvements Demonstrated in Crossover Population

    ONWARD Receives FDA Breakthrough Device Designation for ARC-IM for Blood Pressure and Trunk Control in Spinal Cord Injury

    ONWARD announced the Company has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for their ARC-IM platform...

    Amalgam Rx™ and Novo Nordisk® Plan Global Expansion

    Insulin Titration App, Dose Check®, to Reach Patients Worldwide Amalgam Rx, Inc., the leader in connecting healthcare providers and...

    M&A

    Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

    Elekta Harmony linear accelerator cleared by U.S. Food and Drug Administration Elekta (EKTA-B.ST) announced...

    Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure

    Study Results Validate Superiority of Basivertebral Nerve Ablation Compared to Standard Care, With Similar Improvements Demonstrated in Crossover Population

    ONWARD Receives FDA Breakthrough Device Designation for ARC-IM for Blood Pressure and Trunk Control in Spinal Cord Injury

    ONWARD announced the Company has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for their ARC-IM platform...

    Amalgam Rx™ and Novo Nordisk® Plan Global Expansion

    Insulin Titration App, Dose Check®, to Reach Patients Worldwide Amalgam Rx, Inc., the leader in connecting healthcare providers and...

    Archives

    Latest articles

    Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

    Elekta Harmony linear accelerator cleared by U.S. Food and Drug Administration Elekta (EKTA-B.ST) announced...

    Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure

    Study Results Validate Superiority of Basivertebral Nerve Ablation Compared to Standard Care, With Similar Improvements Demonstrated in Crossover Population

    ONWARD Receives FDA Breakthrough Device Designation for ARC-IM for Blood Pressure and Trunk Control in Spinal Cord Injury

    ONWARD announced the Company has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for their ARC-IM platform...

    Amalgam Rx™ and Novo Nordisk® Plan Global Expansion

    Insulin Titration App, Dose Check®, to Reach Patients Worldwide Amalgam Rx, Inc., the leader in connecting healthcare providers and...

    GV leads $72M investment in startup offering virtual behavioral healthcare for kids

    Brightline focuses on providing virtual behavioral health solutions for kids. The startup plans to put the new funds to use by launching...

    LivaNova Brings the Conversation Back to Neuromodulation with New IDE

    LivaNova is developing the aura6000 System to treat obstructive sleep apnea. The device will be evaluated in the OSPREY RCT Trial. The...

    Popular categories